Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation

被引：0
|
作者：
Chen, G. [1 ]
Zhu, L. [1 ]
Chen, S. [1 ]
Wang, X. [1 ]
Lin, Z. [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Organ Transplantat, Wuhan 430074, Hubei, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1415
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation
    Li, Ling-Fei
    Shi, Ke-Qing
    Lin, Yi-Qian
    Wang, Li-Ren
    He, Jiang-Ping
    Braddock, Martin
    Chen, Yong-Ping
    Zheng, Ming-Hua
    GENE, 2014, 544 (02) : 101 - 106
  • [2] Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C
    Huang, Chung-Feng
    Yang, Jeng-Fu
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hou, Nai-Jen
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 751 - 759
  • [3] Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
    Hu, C. -C.
    Lin, C. -L.
    Kuo, Y. -L.
    Chien, C. -H.
    Chen, S. -W.
    Yen, C. -L.
    Lin, C. -Y.
    Chien, R. -N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 81 - 90
  • [4] Assessment of efficacy and safety of PEGylated interferon plus ribavirin in elderly patients with chronic hepatitis C
    Wen, Shi-Chi
    Cheng, Lung-Chih
    Hsu, Jui-Hung
    Lai, Hsin-Wen
    Shih, Pei-Chen
    Tsai, Chi-Chang
    Lee, Ching-Chang
    Kuo, Wu-Hsien
    ADVANCES IN DIGESTIVE MEDICINE, 2018, 5 (03) : 84 - 92
  • [5] Efficacy and safety of pegylated interferon alpha-2b and ribavirin in chronic hepatitis C in children
    Kups-Rzepecka, Joanna
    Golabek, Violetta
    Kicinski, Przemyslaw
    Wozniakowska-Gesicka, Teresa
    PRZEGLAD GASTROENTEROLOGICZNY, 2010, 5 (06): : 341 - 348
  • [6] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [7] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [8] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [9] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
  • [10] Efficacy and safety of valopicitabine in combination with pegylated interferon-α (pegIFN) and ribavirin (RBV) in patients with chronic hepatitis C
    Poordad, Fred
    Lawitz, Eric J.
    Gitlin, Norman
    Rodriguez-Torres, Maribel
    Box, Terry
    Nguyen, Tuan
    Pietropaolo, Keith
    Liu, Wei
    Fielman, Barbara A.
    Mayers, Douglas
    HEPATOLOGY, 2007, 46 (04) : 866A - 866A
12345